Cargando…
Epigenetic Regulation and Nonepigenetic Mechanisms of Ferroptosis Drive Emerging Nanotherapeutics in Tumor
Currently, traditional cancer therapy still falls far short of expectations. However, a variety of invasive cancers that are resistant to chemotherapy (such as platinum drugs, one of the most applied antineoplastics in clinic) and targeted agents are susceptible to ferroptosis. Ferroptosis is a form...
Autores principales: | Cheng, Yue, Xie, Yao, Chen, Yan, Liu, Xiaojing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7864727/ https://www.ncbi.nlm.nih.gov/pubmed/33574983 http://dx.doi.org/10.1155/2021/8854790 |
Ejemplares similares
-
Metastatic Breast Cancer: Review of Emerging Nanotherapeutics
por: Dissanayake, Ranga, et al.
Publicado: (2023) -
Extracellular vesicle-based Nanotherapeutics: Emerging frontiers in anti-inflammatory therapy
por: Tang, Tao-Tao, et al.
Publicado: (2020) -
The Organelle-Specific Regulations and Epigenetic Regulators in Ferroptosis
por: Zhang, Yixuan, et al.
Publicado: (2022) -
Perturbing plasma membrane lipid: a new paradigm for tumor nanotherapeutics
por: Fei, Weidong, et al.
Publicado: (2023) -
The emerging potential of siRNA nanotherapeutics in treatment of arthritis
por: Kumari, Anjali, et al.
Publicado: (2023)